MiMedx Group (NASDAQ: MDXG) reported Q1 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $53.4 million versus the consensus estimate of $54.06 million.

GUIDANCE:

MiMedx Group sees Q2 2016 revenue of $55.7-57.0 million, versus the consensus of $61.5 million.

MiMedx Group sees FY2016 EPS of $0.30-$0.32, versus the consensus of $0.30.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.